Informed consent to e-therapyRECUPERO, Patricia R; RAINEY, Samara E.American journal of psychotherapy. 2005, Vol 59, Num 4, pp 319-331, issn 0002-9564, 13 p.Article

Characteristics of E-therapy web sitesRECUPERO, Patricia R; RAINEY, Samara E.The Journal of clinical psychiatry. 2006, Vol 67, Num 9, pp 1435-1440, issn 0160-6689, 6 p.Article

Seratrodast (AA-2414) : A novel thromboxane-A₂ receptor antagonistSAMARA, E. E.Cardiovascular drug reviews (Print). 1996, Vol 14, Num 3, pp 272-285, issn 0897-5957Article

Casamento e papéis familiares em Sao Paulo no séc. XIX. in A familia em questao (la famille en question). (Mariage et papiers de famille à Sao Paulo au XIX siècle)MESQUITA SAMARA, E. de.Cadernos de Pesquisa Sâo Paulo. 1981, Num 37, pp 17-25Article

Googling Suicide : Surfing for Suicide Information on the InternetRECUPERO, Patricia R; HARMS, Samara E; NOBLE, Jeffrey M et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 6, pp 878-888, issn 0160-6689, 11 p.Article

Role of population pharmacokinetics in Drug development : A pharmaceutical industry perspectiveSAMARA, E; GRANNEMAN, R.Clinical pharmacokinetics. 1997, Vol 32, Num 4, pp 294-312, issn 0312-5963Article

Rapid high-performance liquid chromatographic assay with pharmacokinetic applications for monitoring cannabidiol in plasmaSAMARA, E; BIALER, M.Journal of chromatography. 1987, Vol 416, Num 2, pp 370-374, issn 0021-9673Article

Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogsSAMARA, E; BIALER, M.Drug metabolism and disposition. 1988, Vol 16, Num 6, pp 875-879, issn 0090-9556Article

Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthmaSAMARA, E; CAO, G; LOCKE, C et al.Clinical pharmacology and therapeutics. 1997, Vol 62, Num 4, pp 426-435, issn 0009-9236Article

Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjectsRAZ, I; BEN-DAVID, J; HUSSEIN, Z et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1988, Vol 26, Num 4, pp 206-208, issn 0174-4879Article

Characterization of the pharmacokinetics and pharmacodynamics of a new oral thromboxane A₂-receptor antagonist AA-2414 in normal subjects : population analysisHUSSEIN, Z; SAMARA, E; LOCKE, C. S et al.Clinical pharmacology and therapeutics. 1994, Vol 55, Num 4, pp 441-450, issn 0009-9236Article

Urinary metabolites of cannabidiol in dog, rat and man and their identification by gas chromatography : mass spectrometryHARVEY, D. J; SAMARA, E; MECHOULAM, R et al.Journal of chromatography. Biomedical applications. 1991, Vol 562, Num 1-2, pp 299-322, issn 0378-4347Conference Paper

Lack of pharmacokinetic interaction between zileuton and phenytoin in humansSAMARA, E; CAVANAUGH, J. H; DEBABRATA MUKHERJEE et al.Clinical pharmacokinetics. 1995, Vol 29, pp 84-91, issn 0312-5963, SUP2Article

Identification of glucose conjugates as major urinary metabolites of cannabidiol in the dogSAMARA, E; BIALER, M; HARVEY, D. J et al.Xenobiotica (London. Print). 1990, Vol 20, Num 2, pp 177-183, issn 0049-8254Article

Microsomal metabolism of th e1,1-dimethlheptyl analogue of cannabidiol : relative percentage of monhohydroxy in four speciesSAMARA, E; BROWN, N. K; HARVEY, D. J et al.Drug metabolism and disposition. 1990, Vol 18, Num 4, pp 548-549, issn 0090-9556, 2 p.Article

Pharmacokinetics of cannabidiol in dogsSAMARA, E; BIALER, M; MECHOULAM, R et al.Drug metabolism and disposition. 1988, Vol 16, Num 3, pp 469-472, issn 0090-9556Article

Instrument intercomparison in the pulsed neutron fieldsat the CERN HiRadMat facilityAZA, E; CARESANA, M; CASSELL, C et al.Radiation measurements. 2014, Vol 61, pp 25-32, issn 1350-4487, 8 p.Article

Once-a-day controlled-release dosage form of divalproex sodium II: Development of a predictive in vitro drug release methodYIHONG QIU; GARREN, J; SAMARA, E et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 11, pp 2317-2325, issn 0022-3549, 9 p.Article

Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxenSAMARA, E; AVNIR, D; LADKANI, D et al.Biopharmaceutics & drug disposition. 1995, Vol 16, Num 3, pp 201-210, issn 0142-2782Article

Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatmentBIALER, M; SALIM HADAD; KAPLAN, R et al.Biopharmaceutics & drug disposition. 1994, Vol 15, Num 1, pp 45-52, issn 0142-2782Article

Comparative metabolism of Cannbidiol in dog, rat and manHARVEY, D. J; SAMARA, E; MECHOULAM, R et al.Pharmacology, biochemistry and behavior. 1991, Vol 40, Num 3, pp 523-532, issn 0091-3057Conference Paper

Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal FunctionLODISE, T. P; BUTTERFIELD, J. M; HEGDE, S. S et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 2062-2066, issn 0066-4804, 5 p.Article

Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazoleZIAD HUSSEIN; GRANNEMAN, G. R; DEBU MUKHERJEE et al.British journal of clinical pharmacology. 1993, Vol 36, Num 5, pp 391-398, issn 0306-5251Conference Paper

Identification of metabolites of the 1, 1-dimethyleptyl analogue of cannabidiol in rat and dog in vivoSAMARA, E; BIALER, M; BAR-ON, H et al.Xenobiotica (London. Print). 1990, Vol 20, Num 5, pp 447-455, issn 0049-8254, 9 p.Article

Identification of urinary metabolites of cannabidiol in the dogSAMARA, E; BIALER, M; HARVEY, D. J et al.Drug metabolism and disposition. 1990, Vol 18, Num 5, pp 571-579, issn 0090-9556, 9 p.Article